Bio

Mort Headshot 2015 (2)Dr. Collins is Founder and Managing Partner of M. Collins Ventures LLC, a Venture Capital Fund focused on Therapeutic Immunology, Ultrafast Lasers and Quantum Computing. Dr. Collins was also Founder and Managing Partner of Battelle Venture Partners in 2003, an early-stage Venture Capital Fund focused on IP from Battelle Laboratories and the six US National Laboratories managed by Battelle for the Department of Energy. In 1968, Dr. Collins founded and served as CEO of Data Science Ventures (DSV), a pioneering venture capital firm that had offices in Princeton, N.J., and Newport Beach, Calif. For 30 years he was a managing partner and demonstrated major successes in four DSV partnerships (DSV I-IV) that specialized in early-stage financing of high-technology companies in the fields of life sciences, electronic materials, communications and software, including Datapoint, General Automation, Tandem Computers, Datacom Systems, The Liposome Company, Apollon and Alkermes. In 1997, he became a special limited partner of Cardinal Partners, the successor to the DSV series of partnerships.

Dr. Collins currently serves as chairman of the Boards of Directors of portfolio companies 360ip Inc. and FemtoBlanc Inc. In addition, Dr. Collins sits on the Boards of publicly traded Kopin Corp. and Inovio Pharmaceuticals, as well as on the Boards of privately held Pharos LLC, Formula Pharmaceuticals, DoughMain, AENEOS Therapeutics, Cerminaro Group LLC and Ascendance Biotechnology (formerly Hepregen). He is also chairman of PD-LD, Inc.’s Board.

Dr. Collins is a member of the Advisory Council to the Chemical & Biomolecular Engineering Department at the University of Delaware, a member of the Leadership Council of the School of Engineering and Applied Sciences at Princeton University, a member of the Graduate School Leadership Council at Princeton University, a member of the Systems Biology Advisory Council at the Institute for Advanced Study, Princeton, N.J. and a member of the President’s Advisory Council at the University of Delaware. He chaired President Ronald Reagan’s Task Force on Innovation and Entrepreneurship and served as a technology policy advisor to President George H.W. Bush. He served on the New Jersey Governor’s Commission on Science and Technology, the New Jersey Governor’s Superconductivity Roundtable and was a member of the Research Roundtable of the National Academy of Sciences. He is also a member of the National Academy of Engineering.

A former president, director and chairman of the National Venture Capital Association, Dr. Collins was the recipient of the 1989 University of Delaware Medal of Distinction, the 1990 New York Venture Forum Award, and the 1992 Delaware Valley Venture Group Award.

Dr. Collins earned his B.S. degree in chemical engineering from the University of Delaware, his M.S. and PhD degrees in chemical engineering from Princeton University, and an honorary PhD in Science from the University of Delaware.